SCHEMBL6187047

SCHEMBL6187047

NC(=O)C(C1CCCCC1)N1CCNCC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 4/20 0.46
SIGMAR1 Q99720 3/20 0.43
CHRM5 P08912 1/20 0.41
CHRM3 P20309 1/20 0.41
OPRD1 P41143 2/20 0.40
OPRM1 P35372 1/20 0.40
OPRK1 P41145 1/20 0.40
CA2 P00918 1/20 0.36
CHKA P35790 1/20 0.36
CHRNB2 P17787 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
CHRNB3 Q05901 1/20 0.35
CHRNA6 Q15825 1/20 0.35
DPP4 P27487 5/20 0.34
DPP7 Q9UHL4 3/20 0.34
KCNH2 Q12809 1/20 0.33
RAD52 P43351 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1555261 0.90 SIGMAR1 (0.35) EPHX1SIGMAR1CHRM5CHRM3OPRD1
SCHEMBL14655522 0.85 EPHX1 (0.52) EPHX1DPP4DPP7KCNH2
SCHEMBL1022186 0.85 CHRNB2 (0.34) SIGMAR1OPRD1CHRNB2CHRNA3CHRNA4
SCHEMBL1022188 0.85 CHRNB2 (0.34) SIGMAR1OPRD1CHRNB2CHRNA3CHRNA4
SCHEMBL1554022 0.81 CHRM2 (0.33) SIGMAR1CHRM3OPRD1CHRNB2CHRNA3
SCHEMBL1555130 0.80 CYP2D6 (0.37) EPHX1SIGMAR1OPRD1OPRM1OPRK1
SCHEMBL1553591 0.80 SIGMAR1 (0.39) SIGMAR1OPRD1OPRM1OPRK1CHRNB2
SCHEMBL1554232 0.80 CYP2D6 (0.37) EPHX1SIGMAR1OPRD1OPRM1OPRK1
SCHEMBL944062 0.79 EPHX1 (0.46) EPHX1CA2DPP4DPP7KCNH2
Hydrochloric Acid SCHEMBL5410658 0.79 CA2 (0.44) SIGMAR1CHRM5CHRM3OPRD1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-A4 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2005-03-30 EP disclosed
EP-1465631-A2 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI Pharmaceuticals, Inc. (US) 2004-10-13 EP disclosed
WO-2003053366-A2 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARMACEUTICALS, INC. (US) 2003-07-03 WO disclosed
US-4495186-A SALT FORMATION WITH A DIHYDROXYALUMINUM-A-HYDROXYCARBAXYLIC ACID CAMILLO CORVI S.P.A. (IT) 1985-01-22 US disclosed